Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 19, Issue 2, 2000, Pages 141-144

  Altinyollar, H ^a,b   Kapucuoglu, N ^a   Pak, I ^a   Berberoglu, U ^a  

^a Ankara Onkoloji   (Turkey)

^b Kavacik Subayevleri   (Turkey)

Author keywords

Breast carcinoma; Sentinel node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER STAGING; EARLY DIAGNOSIS; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; ADULT; AXILLA; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; EOSINE YELLOWISH-(YS); FEMALE; HEMATOXYLIN; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, RADICAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0033925138     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Silverstein M.J., Gierson E.D., Waisman J. R., Senofsky G. M. et al.: Axillary Lymph Node Dissection for Tla Breast Carcinoma; Is it indicated? Cancer 73:664-667, 1994.
2. Kinne D. W.: Controversies in Primary Breast Cancer Management. Am. J. Surg. 166:502-508, 1993.
3. Turner R. R., Ollila D. W., Krasne D. L. and Giuliano A. E.: Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma. Ann.Surg. 226:271-278, 1997.
4. Cady B.: Use of primary breast carcinoma characteristics to predict lymph node metastases. Cancer 79:1856-1861, 1997.
5. Giuliano A. E., Dale P. S., Turner R. R., Morton D. L. et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann. Surg. 222:394-401, 1995.
6. Alberthini J. J., Lyman G. H., Cox C., Yeatman T., et al.: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. Jama 276:1818-1822, 1996.
7. Pandelidis S. M., Peters K. L., Walusimbi M. S., Casady R. L., et al.: The role of axillary dissection in mammographically detected carcinoma. J. Am. Coll. Surg. 184:341-345, 1997.
8. Hoe A. L., Iven D., Royle G. T., Taylor I.: Incidence of arm swelling following axillary clearance for breast cancer. Br. J. Surg. 79:261-262, 1992.
9. Kissin M.W., Querci della Rovere G., Easton D., Westbury G.: Risk of lymphoedema following treatment of breast cancer. Br.J.Surg. 73:580-584, 1986.
10. Fisher C. J., Boyle S., Burke M. and Price A. B.: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br. J. Surg. 80:457-458, 1993.
11. Morton D., Wen D.R., Wong J. et al.: Tecnical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127:664-667, 1992.
12. Veronesi U., Paganelli G., Galimberti V. et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867, 1997.
13. Krag D., Weaver D., Ashikaga T. et al.: The sentinel node in breast cancer: A multicenter validation study. N. Eng. J. Med. 339:941-946, 1998.
14. Giuliano A.E., Jones R.C., Brennan M. et al.: Sentinel lymphadenectomy in breast cancer. J. Clin. Oncol. 15:2345-2350, 1997.
15. Giuliano A.E., Barh A.M., Spivack B̌., Beitsch P.D., Evans S.W.: Incidence and predictors of axillary metastases in Tl carcinoma of the breast. J. Am. Coll. Surg. 183(3):185-189, 1996.
16. Czerniecki B., Scheff A., Callans L. et al.: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel node biopsy in patients with breast cancer. Cancer 85:1098-1103, 1999.
17. Barnwell J.M., Arredondo M.A., Kollmorgen D. et al.: Sentinel node biopsy in breast cancer. Ann. Surg. Oncol. 5:126-130, 1998.
18. Offodile R., Hoh C., Barsky S.H. et al.: Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 82:1704-1708, 1998.
19. Galimberti V., Zurrida S., Zucali P. et al.: Can sentinel node biopsy avoid axillary dissection in clinically node negative breast cancer patients? The Breast 7:8-10, 1998.
20. Reynolds C., Mick R., Donohue J. H., Grant C. S., Farley D. R., Callans L. S. et al.: Sentinel lymph node biopsy with metastases: Can axillary dissection be avoided in some patients with breast cancer? J.Clin.Onc. 17:1720-1726, 1999.
21. O'Hea B. J., Hill A. D. K., El-Shirbiny A. M., Yeh S. D. J. et al.: Sentinel lymh node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J. Am. Coll. Surg. 186:423-427, 1998.
22. Borgstein P. J., Pijjpers R., Comans E. F., van Diest P. J. et al.: Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J. Am.Coll.Surg. 186:275-283, 1998.
23. Cox C. E., Pendas S., Cox J. M., Joseph E., Shons A. R. et al.: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann. Surg. 227:645-653, 1998.
24. Koller M., Barsuk D., Zippel D., Engelberg S., Ben-Ari G. and Papa M. Z.: Sentinel lymph node involvement-a predictor for axillary node status with breast cancer-has the time come? Eur. J. Surg. Onc. 24:166-168, 1998.
25. Hainsworth P. J., Tjandra J. J., Stillwell R. G., Machet D. et al.: Detection and signifiance of occult metastases in node-negative breast cancer. Br. J. Surg. 80:459-463, 1993.
26. Bettelheim R., Price K.N., Gelber R. D. et al.: Prognostic importance of occult axillary lymh node micrometastases from breast cancers. Lancet 335:1565-1568, 1990.
27. Friedman S., Bertin F., Mouriesse H. et al.: Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncologica 27:483-487, 1988.
28. Wilkinson E. J., Hause L. L., Hoffman R. G. et al.: Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and signifiance of the metastases. Pathol. Annu. 17(pt 2):67-91, 1982.
29. White R. E., Vezeridis M. P., Konstadoulakis M., Wanebo H. J. et al.: Therapeutic options and results for the management of minimally invasive carcinoma of breast:influence of axillary dissection for treatment of T1a and T1b lesions. J. Am. Coll. Surg. 183:575-582, 1996.
30. Uren R. F., Howmann-Giles R. B., Thompson J. F., Malouf D. et al.: Mammary Lymphoscintigraphy in Breast Cancer. J. Nucl. Med. 36:1775-1780, 1995.